Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis

Key Points

• Efficacy and safety of different JAK inhibitors vary significantly in treating inflammatory bowel disease.
• The analysis revealed key insights on treatment outcomes across various JAK inhibitors used.
• Network meta-analysis integrates data from multiple studies to evaluate drug effectiveness and safety.
• Findings highlight the necessity for careful treatment selection to maximize patient benefits with JAK inhibitors.